Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 54051 - 54075 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Oxaliplatin	Approved Investigational	MNS1	55329	downregulated	oxaliplatin results in decreased expression of MNS1 mRNA	15q21.3	A22638
Oxaliplatin	Approved Investigational	MT2A	4502	downregulated	oxaliplatin results in decreased expression of MT2A mRNA	16q13	A23410
Oxaliplatin	Approved Investigational	NCBP1	4686	downregulated	oxaliplatin results in decreased expression of NCBP1 mRNA	9q22.33	A23409
Oxaliplatin	Approved Investigational	NEK2	4751	downregulated	oxaliplatin results in decreased expression of NEK2 mRNA	1q32.3	A23409
Oxaliplatin	Approved Investigational	NR2F1	7025	upregulated	oxaliplatin results in increased expression of NR2F1 mRNA	5q15	A23409
Oxaliplatin	Approved Investigational	NUMA1	4926	upregulated	oxaliplatin results in increased expression of NUMA1 mRNA	11q13.4	A23409
Oxaliplatin	Approved Investigational	P4HA1	5033	downregulated	oxaliplatin results in decreased expression of P4HA1 mRNA	10q22.1	A23409
Oxaliplatin	Approved Investigational	P4HA2	8974	downregulated	oxaliplatin results in decreased expression of P4HA2 mRNA	5q31.1	A23409
Oxaliplatin	Approved Investigational	PAICS	10606	upregulated	oxaliplatin results in increased expression of PAICS mRNA	4q12	A23409
Oxaliplatin	Approved Investigational	PAK2	5062	downregulated	oxaliplatin results in decreased expression of PAK2 mRNA	3q29	A23409
Oxaliplatin	Approved Investigational	PCK2	5106	downregulated	oxaliplatin results in decreased expression of PCK2 mRNA	14q11.2-q12	A23409
Oxaliplatin	Approved Investigational	PDF	64146	upregulated	oxaliplatin results in increased expression of PDF mRNA	16q22.1	A22638
Oxaliplatin	Approved Investigational	PFKFB4	5210	downregulated	oxaliplatin results in decreased expression of PFKFB4 mRNA	3p21.31	A23409
Oxaliplatin	Approved Investigational	PFKP	5214	downregulated	oxaliplatin results in decreased expression of PFKP mRNA	10p15.2	A23409
Oxaliplatin	Approved Investigational	PIK3R2	5296	upregulated	oxaliplatin results in increased expression of PIK3R2 mRNA	19p13.11	A23409
Oxaliplatin	Approved Investigational	PKD1	5310	downregulated	oxaliplatin results in decreased expression of PKD1 mRNA	16p13.3	A23409
Oxaliplatin	Approved Investigational	PKIG	11142	downregulated	oxaliplatin results in decreased expression of PKIG mRNA	20q13.12	A23409
Oxaliplatin	Approved Investigational	POLR2E	5434	downregulated	oxaliplatin results in decreased expression of POLR2E mRNA	19p13.3	A23409
Oxaliplatin	Approved Investigational	PPM1G	5496	upregulated	oxaliplatin results in increased expression of PPM1G mRNA	2p23.3	A23409
Oxaliplatin	Approved Investigational	PSAP	5660	upregulated	oxaliplatin results in increased expression of PSAP mRNA	10q22.1	A23409
Oxaliplatin	Approved Investigational	PXDN	7837	upregulated	oxaliplatin results in increased expression of PXDN mRNA	2p25.3	A22638
Oxaliplatin	Approved Investigational	RAP1B	5908	downregulated	oxaliplatin results in decreased expression of RAP1B mRNA	12q15	A23409
Oxaliplatin	Approved Investigational	RGS4	5999	downregulated	oxaliplatin results in decreased expression of RGS4 mRNA	1q23.3	A23409
Oxaliplatin	Approved Investigational	RNF43	54894	upregulated	oxaliplatin results in increased expression of RNF43 mRNA	17q23.2	A22638
Oxaliplatin	Approved Investigational	RPA1	6117	upregulated	oxaliplatin results in increased expression of RPA1 mRNA	17p13.3	A23409

Displaying entries 54051 - 54075 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability